251 related articles for article (PubMed ID: 156764)
21. In vitro generation of specific and nonspecific suppression of cell-mediated cytotoxicity.
Ferguson RM; Anderson SM; Simmons RL
Transplant Proc; 1977 Mar; 9(1):919-21. PubMed ID: 141142
[No Abstract] [Full Text] [Related]
22. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
Okada M; Henney CS
J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
[No Abstract] [Full Text] [Related]
23. Regulatory mechanisms in cell-mediated immune responses. III. Antigen-specific and nonspecific suppressor activities generated during MLC.
Hodes RJ; Nadler LM; Hathcock KS
J Immunol; 1977 Sep; 119(3):961-7. PubMed ID: 70480
[No Abstract] [Full Text] [Related]
24. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
Tracey DE; Wolfe SA; Durdik JM; Henney CS
J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
[No Abstract] [Full Text] [Related]
25. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism of T cell-mediated lysis at the single effector cell level. I. Kinetic analysis of lethal hits and target cell lysis in multicellular conjugates.
Zagury D; Bernard J; Jeannesson P; Thiernesse N; Cerottini JC
J Immunol; 1979 Oct; 123(4):1604-9. PubMed ID: 314465
[No Abstract] [Full Text] [Related]
27. Accessory cell requirements for the generation of cytolytic T lymphocytes.
Lutz CT; Fitch FW
J Immunol; 1979 Jun; 122(6):2598-604. PubMed ID: 109533
[TBL] [Abstract][Full Text] [Related]
28. Studies on the induction and expression of T cell-mediated immunity. VII. Inactivation of autologous cytotoxic T lymphocytes when used as both effectors and targets in a lectin-dependent cellular cytotoxic reaction.
Bradley TP; Bonavida B
Transplantation; 1978 Oct; 26(4):212-7. PubMed ID: 309197
[No Abstract] [Full Text] [Related]
29. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
Ting CC; Rodrigues D
J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
[TBL] [Abstract][Full Text] [Related]
30. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
Dennert G; Lennox ES
J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
[No Abstract] [Full Text] [Related]
31. Suppressor cells in the spleen of tumor-allosensitized mice.
Argyris BF
Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
[TBL] [Abstract][Full Text] [Related]
32. Cytolytic T lymphocytes recognize alloantigens on schistosomula of Schistosoma mansoni, but fail to induce damage.
Butterworth AE; Vadas MA; Martz E; Sher A
J Immunol; 1979 Apr; 122(4):1314-21. PubMed ID: 312837
[No Abstract] [Full Text] [Related]
33. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
Bonavida B
J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
[No Abstract] [Full Text] [Related]
34. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
Jones B; Jones TC
Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte.
Perelson AS; Macken CA; Grimm EA; Roos LS; Bonavida B
J Immunol; 1984 May; 132(5):2190-8. PubMed ID: 6609191
[TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte.
Vallera DA; Gamble CE; Schmidtke JR
J Immunol; 1980 Feb; 124(2):641-9. PubMed ID: 6444315
[No Abstract] [Full Text] [Related]
37. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
[TBL] [Abstract][Full Text] [Related]
38. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
Parker WL; Martz E
J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
[No Abstract] [Full Text] [Related]
39. Proliferative response of T lymphocytes to allogeneic tumor without generation of killer T lymphocytes in the presence of Ehrlich ascites tumor fluid.
Laurence JC; Hamaoka T; Kitagawa M
Gan; 1976 Jun; 67(3):417-23. PubMed ID: 137160
[TBL] [Abstract][Full Text] [Related]
40. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
Williams RM; Germain RN; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
